Use and Prognostic Implications of Cardiac Troponin in COVID-19

Myocardial injury is common in patients with COVID-19 and is associated with an adverse prognosis. Cardiac troponin (cTn) is used to detect myocardial injury and assist with risk stratification in this population. SARS-CoV-2 infection can play a role in the pathogenesis of acute myocardial injury due to both direct and indirect damage of the cardiovascular system. Despite the initial concerns for an increased incidence of acute myocardial infarction, most cTn increases are related to chronic myocardial injury due to comorbidities and/or acute non-ischemic myocardial injury. This review will discuss the latest findings on this topic.
Source: Cardiology Clinics - Category: Cardiology Authors: Source Type: research